APO Research

APO RESEARCH · REPORT

Drug and Medical Device Testing

Selected research

Market Analysis & Forecast

Global Drug and Medical Device Testing Market Analysis and Forecast 2026-2032

Market perspective

The global Drug and Medical Device Testing market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Drug and Medical Device Testing is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Drug and Medical Device Testing is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Drug and Medical Device Testing is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Drug and Medical Device Testing is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Drug and Medical Device Testing include SGS, Beijing Pony Testing Company, GTTC, Shanghai International Certification Assessment Services Co.,Ltd., Guangdong Sino-sci Testing Technology Corporation Limited, GBT, FUDA TESTING GROUP, Shimadzu(Guangzhou)Analysis&Technology Services Co.,Ltd. and Guangdong Lewwin Pharmaceutical Research Institute Co.,Ltd., etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Drug and Medical Device Testing, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Drug and Medical Device Testing, also provides the revenue of main regions and countries. Of the upcoming market potential for Drug and Medical Device Testing, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Drug and Medical Device Testing revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Drug and Medical Device Testing market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Drug and Medical Device Testing revenue, projected growth trends, production technology, application and end-user industry.

Drug and Medical Device Testing Segment by Company

SGS

Beijing Pony Testing Company

GTTC

Shanghai International Certification Assessment Services Co.,Ltd.

Guangdong Sino-sci Testing Technology Corporation Limited

GBT

FUDA TESTING GROUP

Shimadzu(Guangzhou)Analysis&Technology Services Co.,Ltd.

Guangdong Lewwin Pharmaceutical Research Institute Co.,Ltd.

Guangzhou Medicine Industry Research Institute

Drug and Medical Device Testing Segment by Type

Drug Testing

Medical Device Testing

Drug and Medical Device Testing Segment by Application

Pharmaceutical Products Manufacturer

Medical Device Manufacturer

Drug and Medical Device Testing Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Drug and Medical Device Testing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Drug and Medical Device Testing and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Drug and Medical Device Testing.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Drug and Medical Device Testing in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Drug and Medical Device Testing company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Drug and Medical Device Testing revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Drug and Medical Device Testing Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Drug Testing Major Player Table 3. Medical Device Testing Major Player Table 4. Global Drug and Medical Device Testing Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Pharmaceutical Products Manufacturer Major Player Table 6. Medical Device Manufacturer Major Player Table 7. Drug and Medical Device Testing Industry Trends Table 8. Drug and Medical Device Testing Industry Drivers Table 9. Drug and Medical Device Testing Industry Opportunities and Challenges Table 10. Drug and Medical Device Testing Industry Restraints Table 11. Global Drug and Medical Device Testing Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 12. Global Drug and Medical Device Testing Market Size by Region (2021-2026) & (US$ Million) Table 13. Global Drug and Medical Device Testing Market Share by Region (2021-2026) Table 14. Global Drug and Medical Device Testing Market Size by Region (2027-2032) & (US$ Million) Table 15. Global Drug and Medical Device Testing Market Share by Region (2027-2032) Table 16. Global Drug and Medical Device Testing Revenue by Players (US$ Million) & (2021-2026) Table 17. Global Drug and Medical Device Testing Revenue Market Share by Players (2021-2026) Table 18. Global Drug and Medical Device Testing Key Players Ranking, 2024 VS 2025 VS 2026 Table 19. Global Drug and Medical Device Testing Key Players Headquarters & Area Served Table 20. Global Drug and Medical Device Testing Players, Product Type & Application Table 21. Global Drug and Medical Device Testing Players Establishment Date Table 22. Global Players Market Concentration Ratio (CR5 and HHI) Table 23. Global Drug and Medical Device Testing by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 24. Global Drug and Medical Device Testing Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Drug and Medical Device Testing Revenue by Type (2021-2026) & (US$ Million) Table 26. Global Drug and Medical Device Testing Revenue by Type (2027-2032) & (US$ Million) Table 27. Global Drug and Medical Device Testing Revenue Market Share by Type (2021-2026) Table 28. Global Drug and Medical Device Testing Revenue Market Share by Type (2027-2032) Table 29. Global Drug and Medical Device Testing Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Drug and Medical Device Testing Revenue by Application (2021-2026) & (US$ Million) Table 31. Global Drug and Medical Device Testing Revenue by Application (2027-2032) & (US$ Million) Table 32. Global Drug and Medical Device Testing Revenue Market Share by Application (2021-2026) Table 33. Global Drug and Medical Device Testing Revenue Market Share by Application (2027-2032) Table 34. SGS Company Information Table 35. SGS Business Overview Table 36. SGS Drug and Medical Device Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 37. SGS Drug and Medical Device Testing Product Portfolio Table 38. SGS Recent Development Table 39. Beijing Pony Testing Company Company Information Table 40. Beijing Pony Testing Company Business Overview Table 41. Beijing Pony Testing Company Drug and Medical Device Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 42. Beijing Pony Testing Company Drug and Medical Device Testing Product Portfolio Table 43. Beijing Pony Testing Company Recent Development Table 44. GTTC Company Information Table 45. GTTC Business Overview Table 46. GTTC Drug and Medical Device Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 47. GTTC Drug and Medical Device Testing Product Portfolio Table 48. GTTC Recent Development Table 49. Shanghai International Certification Assessment Services Co.,Ltd. Company Information Table 50. Shanghai International Certification Assessment Services Co.,Ltd. Business Overview Table 51. Shanghai International Certification Assessment Services Co.,Ltd. Drug and Medical Device Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 52. Shanghai International Certification Assessment Services Co.,Ltd. Drug and Medical Device Testing Product Portfolio Table 53. Shanghai International Certification Assessment Services Co.,Ltd. Recent Development Table 54. Guangdong Sino-sci Testing Technology Corporation Limited Company Information Table 55. Guangdong Sino-sci Testing Technology Corporation Limited Business Overview Table 56. Guangdong Sino-sci Testing Technology Corporation Limited Drug and Medical Device Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 57. Guangdong Sino-sci Testing Technology Corporation Limited Drug and Medical Device Testing Product Portfolio Table 58. Guangdong Sino-sci Testing Technology Corporation Limited Recent Development Table 59. GBT Company Information Table 60. GBT Business Overview Table 61. GBT Drug and Medical Device Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 62. GBT Drug and Medical Device Testing Product Portfolio Table 63. GBT Recent Development Table 64. FUDA TESTING GROUP Company Information Table 65. FUDA TESTING GROUP Business Overview Table 66. FUDA TESTING GROUP Drug and Medical Device Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 67. FUDA TESTING GROUP Drug and Medical Device Testing Product Portfolio Table 68. FUDA TESTING GROUP Recent Development Table 69. Shimadzu(Guangzhou)Analysis&Technology Services Co.,Ltd. Company Information Table 70. Shimadzu(Guangzhou)Analysis&Technology Services Co.,Ltd. Business Overview Table 71. Shimadzu(Guangzhou)Analysis&Technology Services Co.,Ltd. Drug and Medical Device Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 72. Shimadzu(Guangzhou)Analysis&Technology Services Co.,Ltd. Drug and Medical Device Testing Product Portfolio Table 73. Shimadzu(Guangzhou)Analysis&Technology Services Co.,Ltd. Recent Development Table 74. Guangdong Lewwin Pharmaceutical Research Institute Co.,Ltd. Company Information Table 75. Guangdong Lewwin Pharmaceutical Research Institute Co.,Ltd. Business Overview Table 76. Guangdong Lewwin Pharmaceutical Research Institute Co.,Ltd. Drug and Medical Device Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 77. Guangdong Lewwin Pharmaceutical Research Institute Co.,Ltd. Drug and Medical Device Testing Product Portfolio Table 78. Guangdong Lewwin Pharmaceutical Research Institute Co.,Ltd. Recent Development Table 79. Guangzhou Medicine Industry Research Institute Company Information Table 80. Guangzhou Medicine Industry Research Institute Business Overview Table 81. Guangzhou Medicine Industry Research Institute Drug and Medical Device Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 82. Guangzhou Medicine Industry Research Institute Drug and Medical Device Testing Product Portfolio Table 83. Guangzhou Medicine Industry Research Institute Recent Development Table 84. North America Drug and Medical Device Testing Revenue by Type (2021-2026) & (US$ Million) Table 85. North America Drug and Medical Device Testing Revenue by Type (2027-2032) & (US$ Million) Table 86. North America Drug and Medical Device Testing Revenue by Application (2021-2026) & (US$ Million) Table 87. North America Drug and Medical Device Testing Revenue by Application (2027-2032) & (US$ Million) Table 88. North America Drug and Medical Device Testing Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 89. North America Drug and Medical Device Testing Revenue by Country (2021-2026) & (US$ Million) Table 90. North America Drug and Medical Device Testing Revenue by Country (US$ Million) & (2027-2032) Table 91. Europe Drug and Medical Device Testing Revenue by Type (2021-2026) & (US$ Million) Table 92. Europe Drug and Medical Device Testing Revenue by Type (2027-2032) & (US$ Million) Table 93. Europe Drug and Medical Device Testing Revenue by Application (2021-2026) & (US$ Million) Table 94. Europe Drug and Medical Device Testing Revenue by Application (2027-2032) & (US$ Million) Table 95. Europe Drug and Medical Device Testing Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 96. Europe Drug and Medical Device Testing Revenue by Country (2021-2026) & (US$ Million) Table 97. Europe Drug and Medical Device Testing Revenue by Country (US$ Million) & (2027-2032) Table 98. China Drug and Medical Device Testing Revenue by Type (2021-2026) & (US$ Million) Table 99. China Drug and Medical Device Testing Revenue by Type (2027-2032) & (US$ Million) Table 100. China Drug and Medical Device Testing Revenue by Application (2021-2026) & (US$ Million) Table 101. China Drug and Medical Device Testing Revenue by Application (2027-2032) & (US$ Million) Table 102. Asia Drug and Medical Device Testing Revenue by Type (2021-2026) & (US$ Million) Table 103. Asia Drug and Medical Device Testing Revenue by Type (2027-2032) & (US$ Million) Table 104. Asia Drug and Medical Device Testing Revenue by Application (2021-2026) & (US$ Million) Table 105. Asia Drug and Medical Device Testing Revenue by Application (2027-2032) & (US$ Million) Table 106. Asia Drug and Medical Device Testing Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 107. Asia Drug and Medical Device Testing Revenue by Region (US$ Million) & (2021-2026) Table 108. Asia Drug and Medical Device Testing Revenue by Region (US$ Million) & (2027-2032) Table 109. SAMEA Drug and Medical Device Testing Revenue by Type (2021-2026) & (US$ Million) Table 110. SAMEA Drug and Medical Device Testing Revenue by Type (2027-2032) & (US$ Million) Table 111. SAMEA Drug and Medical Device Testing Revenue by Application (2021-2026) & (US$ Million) Table 112. SAMEA Drug and Medical Device Testing Revenue by Application (2027-2032) & (US$ Million) Table 113. SAMEA Drug and Medical Device Testing Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 114. SAMEA Drug and Medical Device Testing Revenue by Country (2021-2026) & (US$ Million) Table 115. SAMEA Drug and Medical Device Testing Revenue by Country (US$ Million) & (2027-2032) Table 116. Research Programs/Design for This Report Table 117. Authors List of This Report Table 118. Secondary Sources Table 119. Primary Sources List of Figures Figure 1. Drug and Medical Device Testing Image Figure 2. Global Drug and Medical Device Testing Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Drug and Medical Device Testing Market Size Share 2021 VS 2025 VS 2032 Figure 4. Drug Testing Image Figure 5. Medical Device Testing Image Figure 6. Global Drug and Medical Device Testing Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Drug and Medical Device Testing Market Size Share 2021 VS 2025 VS 2032 Figure 8. Pharmaceutical Products Manufacturer Image Figure 9. Medical Device Manufacturer Image Figure 10. Global Drug and Medical Device Testing Market Size (US$ Million) & (2021-2032) Figure 11. Global Drug and Medical Device Testing Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Drug and Medical Device Testing Market Share by Region: 2021 VS 2025 VS 2032 Figure 13. Global Drug and Medical Device Testing Players Revenue Share Top 10 and Top 5 in 2025 Figure 14. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 15. Global Drug and Medical Device Testing Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Drug and Medical Device Testing Revenue Market Share 2021 VS 2025 VS 2032 Figure 17. Global Drug and Medical Device Testing Revenue Market Share by Type (2021-2032) Figure 18. Global Drug and Medical Device Testing Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Drug and Medical Device Testing Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 20. Global Drug and Medical Device Testing Revenue Market Share by Application (2021-2032) Figure 21. North America Drug and Medical Device Testing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 22. North America Drug and Medical Device Testing Revenue Share by Type (2021-2032) Figure 23. North America Drug and Medical Device Testing Revenue Share by Application (2021-2032) Figure 24. North America Drug and Medical Device Testing Revenue Share by Country (2021-2032) Figure 25. United States Drug and Medical Device Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 26. Canada Drug and Medical Device Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 27. Mexico Drug and Medical Device Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Europe Drug and Medical Device Testing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 29. Europe Drug and Medical Device Testing Revenue Share by Type (2021-2032) Figure 30. Europe Drug and Medical Device Testing Revenue Share by Application (2021-2032) Figure 31. Europe Drug and Medical Device Testing Revenue Share by Country (2021-2032) Figure 32. Germany Drug and Medical Device Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 33. France Drug and Medical Device Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 34. U.K. Drug and Medical Device Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. Italy Drug and Medical Device Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. Spain Drug and Medical Device Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Russia Drug and Medical Device Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Netherlands Drug and Medical Device Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Nordic Countries Drug and Medical Device Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. China Drug and Medical Device Testing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 41. China Drug and Medical Device Testing Revenue Share by Type (2021-2032) Figure 42. China Drug and Medical Device Testing Revenue Share by Application (2021-2032) Figure 43. Asia Drug and Medical Device Testing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 44. Asia Drug and Medical Device Testing Revenue Share by Type (2021-2032) Figure 45. Asia Drug and Medical Device Testing Revenue Share by Application (2021-2032) Figure 46. Asia Drug and Medical Device Testing Revenue Share by Region (2021-2032) Figure 47. Japan Drug and Medical Device Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 48. South Korea Drug and Medical Device Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 49. India Drug and Medical Device Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. Australia Drug and Medical Device Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. Taiwan Drug and Medical Device Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Southeast Asia Drug and Medical Device Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. SAMEA Drug and Medical Device Testing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 54. SAMEA Drug and Medical Device Testing Revenue Share by Type (2021-2032) Figure 55. SAMEA Drug and Medical Device Testing Revenue Share by Application (2021-2032) Figure 56. SAMEA Drug and Medical Device Testing Revenue Share by Country (2021-2032) Figure 57. Brazil Drug and Medical Device Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 58. Argentina Drug and Medical Device Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 59. Chile Drug and Medical Device Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Colombia Drug and Medical Device Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Peru Drug and Medical Device Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Saudi Arabia Drug and Medical Device Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Israel Drug and Medical Device Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. UAE Drug and Medical Device Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Turkey Drug and Medical Device Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Iran Drug and Medical Device Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Egypt Drug and Medical Device Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Years Considered Figure 69. Research Process Figure 70. Key Executives Interviewed

Scope & coverage.

Types
  • Drug Testing
  • Medical Device Testing
Applications
  • Pharmaceutical Products Manufacturer
  • Medical Device Manufacturer
Companies covered
  • SGS
  • Beijing Pony Testing Company
  • GTTC
  • Shanghai International Certification Assessment Services Co.,Ltd.
  • Guangdong Sino-sci Testing Technology Corporation Limited
  • GBT
  • FUDA TESTING GROUP
  • Shimadzu(Guangzhou)Analysis&Technology Services Co.,Ltd.
  • Guangdong Lewwin Pharmaceutical Research Institute Co.,Ltd.
  • Guangzhou Medicine Industry Research Institute

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Drug and Medical Device Testing Market by Type
  3. 1.2.1 Global Drug and Medical Device Testing Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Drug Testing
  5. 1.2.3 Medical Device Testing
  6. 1.3 Drug and Medical Device Testing Market by Application
  7. 1.3.1 Global Drug and Medical Device Testing Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Pharmaceutical Products Manufacturer
  9. 1.3.3 Medical Device Manufacturer
  10. 1.4 Assumptions and Limitations
  11. 1.5 Study Goals and Objectives
2 Drug and Medical Device Testing Market Dynamics
  1. 2.1 Drug and Medical Device Testing Industry Trends
  2. 2.2 Drug and Medical Device Testing Industry Drivers
  3. 2.3 Drug and Medical Device Testing Industry Opportunities and Challenges
  4. 2.4 Drug and Medical Device Testing Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Drug and Medical Device Testing Market Perspective (2021-2032)
  2. 3.2 Global Drug and Medical Device Testing Growth Trends by Region
  3. 3.2.1 Global Drug and Medical Device Testing Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Drug and Medical Device Testing Market Size by Region (2021-2026)
  5. 3.2.3 Global Drug and Medical Device Testing Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Drug and Medical Device Testing Revenue by Players
  2. 4.1.1 Global Drug and Medical Device Testing Revenue by Players (2021-2026)
  3. 4.1.2 Global Drug and Medical Device Testing Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Drug and Medical Device Testing Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Drug and Medical Device Testing Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Drug and Medical Device Testing Key Players Headquarters & Area Served
  7. 4.4 Global Drug and Medical Device Testing Players, Product Type & Application
  8. 4.5 Global Drug and Medical Device Testing Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Drug and Medical Device Testing Market CR5 and HHI
  11. 4.6.3 2025 Drug and Medical Device Testing Tier 1, Tier 2, and Tier 3
5 Drug and Medical Device Testing Market Size by Type
  1. 5.1 Global Drug and Medical Device Testing Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Drug and Medical Device Testing Revenue by Type (2021-2032)
  3. 5.3 Global Drug and Medical Device Testing Revenue Market Share by Type (2021-2032)
6 Drug and Medical Device Testing Market Size by Application
  1. 6.1 Global Drug and Medical Device Testing Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Drug and Medical Device Testing Revenue by Application (2021-2032)
  3. 6.3 Global Drug and Medical Device Testing Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 SGS
  2. 7.1.1 SGS Company Information
  3. 7.1.2 SGS Business Overview
  4. 7.1.3 SGS Drug and Medical Device Testing Revenue and Gross Margin (2021-2026)
  5. 7.1.4 SGS Drug and Medical Device Testing Product Portfolio
  6. 7.1.5 SGS Recent Developments
  7. 7.2 Beijing Pony Testing Company
  8. 7.2.1 Beijing Pony Testing Company Company Information
  9. 7.2.2 Beijing Pony Testing Company Business Overview
  10. 7.2.3 Beijing Pony Testing Company Drug and Medical Device Testing Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Beijing Pony Testing Company Drug and Medical Device Testing Product Portfolio
  12. 7.2.5 Beijing Pony Testing Company Recent Developments
  13. 7.3 GTTC
  14. 7.3.1 GTTC Company Information
  15. 7.3.2 GTTC Business Overview
  16. 7.3.3 GTTC Drug and Medical Device Testing Revenue and Gross Margin (2021-2026)
  17. 7.3.4 GTTC Drug and Medical Device Testing Product Portfolio
  18. 7.3.5 GTTC Recent Developments
  19. 7.4 Shanghai International Certification Assessment Services Co.,Ltd.
  20. 7.4.1 Shanghai International Certification Assessment Services Co.,Ltd. Company Information
  21. 7.4.2 Shanghai International Certification Assessment Services Co.,Ltd. Business Overview
  22. 7.4.3 Shanghai International Certification Assessment Services Co.,Ltd. Drug and Medical Device Testing Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Shanghai International Certification Assessment Services Co.,Ltd. Drug and Medical Device Testing Product Portfolio
  24. 7.4.5 Shanghai International Certification Assessment Services Co.,Ltd. Recent Developments
  25. 7.5 Guangdong Sino-sci Testing Technology Corporation Limited
  26. 7.5.1 Guangdong Sino-sci Testing Technology Corporation Limited Company Information
  27. 7.5.2 Guangdong Sino-sci Testing Technology Corporation Limited Business Overview
  28. 7.5.3 Guangdong Sino-sci Testing Technology Corporation Limited Drug and Medical Device Testing Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Guangdong Sino-sci Testing Technology Corporation Limited Drug and Medical Device Testing Product Portfolio
  30. 7.5.5 Guangdong Sino-sci Testing Technology Corporation Limited Recent Developments
  31. 7.6 GBT
  32. 7.6.1 GBT Company Information
  33. 7.6.2 GBT Business Overview
  34. 7.6.3 GBT Drug and Medical Device Testing Revenue and Gross Margin (2021-2026)
  35. 7.6.4 GBT Drug and Medical Device Testing Product Portfolio
  36. 7.6.5 GBT Recent Developments
  37. 7.7 FUDA TESTING GROUP
  38. 7.7.1 FUDA TESTING GROUP Company Information
  39. 7.7.2 FUDA TESTING GROUP Business Overview
  40. 7.7.3 FUDA TESTING GROUP Drug and Medical Device Testing Revenue and Gross Margin (2021-2026)
  41. 7.7.4 FUDA TESTING GROUP Drug and Medical Device Testing Product Portfolio
  42. 7.7.5 FUDA TESTING GROUP Recent Developments
  43. 7.8 Shimadzu(Guangzhou)Analysis&Technology Services Co.,Ltd.
  44. 7.8.1 Shimadzu(Guangzhou)Analysis&Technology Services Co.,Ltd. Company Information
  45. 7.8.2 Shimadzu(Guangzhou)Analysis&Technology Services Co.,Ltd. Business Overview
  46. 7.8.3 Shimadzu(Guangzhou)Analysis&Technology Services Co.,Ltd. Drug and Medical Device Testing Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Shimadzu(Guangzhou)Analysis&Technology Services Co.,Ltd. Drug and Medical Device Testing Product Portfolio
  48. 7.8.5 Shimadzu(Guangzhou)Analysis&Technology Services Co.,Ltd. Recent Developments
  49. 7.9 Guangdong Lewwin Pharmaceutical Research Institute Co.,Ltd.
  50. 7.9.1 Guangdong Lewwin Pharmaceutical Research Institute Co.,Ltd. Company Information
  51. 7.9.2 Guangdong Lewwin Pharmaceutical Research Institute Co.,Ltd. Business Overview
  52. 7.9.3 Guangdong Lewwin Pharmaceutical Research Institute Co.,Ltd. Drug and Medical Device Testing Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Guangdong Lewwin Pharmaceutical Research Institute Co.,Ltd. Drug and Medical Device Testing Product Portfolio
  54. 7.9.5 Guangdong Lewwin Pharmaceutical Research Institute Co.,Ltd. Recent Developments
  55. 7.10 Guangzhou Medicine Industry Research Institute
  56. 7.10.1 Guangzhou Medicine Industry Research Institute Company Information
  57. 7.10.2 Guangzhou Medicine Industry Research Institute Business Overview
  58. 7.10.3 Guangzhou Medicine Industry Research Institute Drug and Medical Device Testing Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Guangzhou Medicine Industry Research Institute Drug and Medical Device Testing Product Portfolio
  60. 7.10.5 Guangzhou Medicine Industry Research Institute Recent Developments
8 North America
  1. 8.1 North America Drug and Medical Device Testing Revenue (2021-2032)
  2. 8.2 North America Drug and Medical Device Testing Revenue by Type (2021-2032)
  3. 8.2.1 North America Drug and Medical Device Testing Revenue by Type (2021-2026)
  4. 8.2.2 North America Drug and Medical Device Testing Revenue by Type (2027-2032)
  5. 8.3 North America Drug and Medical Device Testing Revenue Share by Type (2021-2032)
  6. 8.4 North America Drug and Medical Device Testing Revenue by Application (2021-2032)
  7. 8.4.1 North America Drug and Medical Device Testing Revenue by Application (2021-2026)
  8. 8.4.2 North America Drug and Medical Device Testing Revenue by Application (2027-2032)
  9. 8.5 North America Drug and Medical Device Testing Revenue Share by Application (2021-2032)
  10. 8.6 North America Drug and Medical Device Testing Revenue by Country
  11. 8.6.1 North America Drug and Medical Device Testing Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Drug and Medical Device Testing Revenue by Country (2021-2026)
  13. 8.6.3 North America Drug and Medical Device Testing Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Drug and Medical Device Testing Revenue (2021-2032)
  2. 9.2 Europe Drug and Medical Device Testing Revenue by Type (2021-2032)
  3. 9.2.1 Europe Drug and Medical Device Testing Revenue by Type (2021-2026)
  4. 9.2.2 Europe Drug and Medical Device Testing Revenue by Type (2027-2032)
  5. 9.3 Europe Drug and Medical Device Testing Revenue Share by Type (2021-2032)
  6. 9.4 Europe Drug and Medical Device Testing Revenue by Application (2021-2032)
  7. 9.4.1 Europe Drug and Medical Device Testing Revenue by Application (2021-2026)
  8. 9.4.2 Europe Drug and Medical Device Testing Revenue by Application (2027-2032)
  9. 9.5 Europe Drug and Medical Device Testing Revenue Share by Application (2021-2032)
  10. 9.6 Europe Drug and Medical Device Testing Revenue by Country
  11. 9.6.1 Europe Drug and Medical Device Testing Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Drug and Medical Device Testing Revenue by Country (2021-2026)
  13. 9.6.3 Europe Drug and Medical Device Testing Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Drug and Medical Device Testing Revenue (2021-2032)
  2. 10.2 China Drug and Medical Device Testing Revenue by Type (2021-2032)
  3. 10.2.1 China Drug and Medical Device Testing Revenue by Type (2021-2026)
  4. 10.2.2 China Drug and Medical Device Testing Revenue by Type (2027-2032)
  5. 10.3 China Drug and Medical Device Testing Revenue Share by Type (2021-2032)
  6. 10.4 China Drug and Medical Device Testing Revenue by Application (2021-2032)
  7. 10.4.1 China Drug and Medical Device Testing Revenue by Application (2021-2026)
  8. 10.4.2 China Drug and Medical Device Testing Revenue by Application (2027-2032)
  9. 10.5 China Drug and Medical Device Testing Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Drug and Medical Device Testing Revenue (2021-2032)
  2. 11.2 Asia Drug and Medical Device Testing Revenue by Type (2021-2032)
  3. 11.2.1 Asia Drug and Medical Device Testing Revenue by Type (2021-2026)
  4. 11.2.2 Asia Drug and Medical Device Testing Revenue by Type (2027-2032)
  5. 11.3 Asia Drug and Medical Device Testing Revenue Share by Type (2021-2032)
  6. 11.4 Asia Drug and Medical Device Testing Revenue by Application (2021-2032)
  7. 11.4.1 Asia Drug and Medical Device Testing Revenue by Application (2021-2026)
  8. 11.4.2 Asia Drug and Medical Device Testing Revenue by Application (2027-2032)
  9. 11.5 Asia Drug and Medical Device Testing Revenue Share by Application (2021-2032)
  10. 11.6 Asia Drug and Medical Device Testing Revenue by Country
  11. 11.6.1 Asia Drug and Medical Device Testing Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Drug and Medical Device Testing Revenue by Country (2021-2026)
  13. 11.6.3 Asia Drug and Medical Device Testing Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Drug and Medical Device Testing Revenue (2021-2032)
  2. 12.2 SAMEA Drug and Medical Device Testing Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Drug and Medical Device Testing Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Drug and Medical Device Testing Revenue by Type (2027-2032)
  5. 12.3 SAMEA Drug and Medical Device Testing Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Drug and Medical Device Testing Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Drug and Medical Device Testing Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Drug and Medical Device Testing Revenue by Application (2027-2032)
  9. 12.5 SAMEA Drug and Medical Device Testing Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Drug and Medical Device Testing Revenue by Country
  11. 12.6.1 SAMEA Drug and Medical Device Testing Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Drug and Medical Device Testing Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Drug and Medical Device Testing Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research